This website requires that cookies are enabled. Please enable cookies in your web browser to continue.
Click Here to learn more about cookies and how to enable them.
Once you have enabled cookies, please Click Here to continue.
CYSTORELIN IMPORTANT SAFETY INFORMATION: Do not use in humans. Keep this and all drugs out of the reach of children.
DRY-CLOX RESIDUE WARNINGS: For use in dry cows only. Not to be used within 30 days of calving. Any animal infused with this product must not be slaughtered for food until 30 days after the latest infusion. Precautions: Because it is a derivative of 6-aminopenicillanic acid, DRY-CLOX has the potential for producing allergic reactions. Such reactions are rare; however, should they occur, the subject should be treated with antihistamines or pressor amines, such as epinephrine.
IVOMEC PLUS IMPORTANT SAFETY INFORMATION: Do not treat cattle within 21 days of slaughter. Do not use in female dairy cattle of breeding age or in veal calves. Do not use in other animal species not on the label, as severe adverse reactions, including fatalities in dogs, may result.
IVOMEC POUR-ON IMPORTANT SAFETY INFORMATION: Do not treat cattle within 48 days of slaughter. Do not use in female dairy cattle of breeding age or in veal calves. Do not use in other animal species not on the label, as severe adverse reactions, including fatalities in dogs, may result.
EPRINEX IMPORTANT SAFETY INFORMATION: No meat or milk withdrawal is required when used according to label. Do not use in calves intended for veal or unapproved animal species, as severe adverse reactions, including fatalities in dogs, may result.
LOCKOUT WITHDRAWAL INFORMATION: LOCKOUT requires no milk or pre-slaughter withdrawal when used alone. If dry cow treatment is used in conjunction with LOCKOUT, follow recommended antibiotic withdrawal times per the label.
LONGRANGE IMPORTANT SAFETY INFORMATION: Do not treat within 48 days of slaughter. Not for use in female dairy cattle 20 months of age or older, including dry dairy cows, or in veal calves. Post-injection site damage (e.g., granulomas, necrosis) can occur. These reactions have disappeared without treatment. Not for use in breeding bulls, or in calves less than 3 months of age. Not for use in cattle managed in feedlots or under intensive rotational grazing.
POLYFLEX RESIDUE WARNING: Do not treat cattle for more than 7 days. Milk from treated cows must not be used for food during treatment, and for 48 hours (4 milkings) after the last treatment. Cattle must not be slaughtered for food during treatment, and for 144 hours (6 days) after the last treatment.
SYNANTHIC RESIDUE WARNINGS: Cattle must not be slaughtered until seven days after treatment. Because a withdrawal time in milk has not been established, do not use in female dairy cattle of breeding age.
SYNCHSURE IMPORTANT SAFETY INFORMATION: For animal use only, not for human use. Keep out of reach of children. Women of childbearing age, asthmatics, and persons with bronchial and other respiratory problems should exercise extreme caution when handling this product. In the early stages women may be unaware of their pregnancies. SYNCHSURE is readily absorbed through the skin and may cause abortion and/or bronchospasms: direct contact with the skin should therefore be avoided. Accidental spillage on the skin should be washed off immediately with soap and water.
ToMORROW RESIDUE WARNINGS: For use in dry cows only. Not to be used within 30 days of calving. Milk from treated cows must not be used for food during the first 72 hours after calving. Any animal infused with this product must not be slaughtered for food until 42 days after the latest infusion.
CYSTORELIN®, DRY-CLOX®, EPRINEX®, EXPRESS®, J-VAC®, IVOMEC®, LONGRANGE®, POLYFLEX®, PRESPONSE®, PYRAMID®, SYNANTHIC®, SYNCHSURE® and ToMORROW® are registered trademarks of Boehringer Ingelheim Animal Health USA Inc. BOVIKALC® and LOCKOUT® are registered trademarks of Boehringer Ingelheim Vetmedica GmbH, used under license.
©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-BOV-0572-2022-V2